ロード中...
4CPS-111 Efectiveness and cost of abiraterone and enzalutamide in prostate cancer
BACKGROUND: Abiraterone and enzalutamide are expensive drugs used in hospitals for metastatic prostate cancer and it is necessary to evaluate health outcomes from its use to establish whether it is cost effective PURPOSE: To analyse the effectiveness and cost of abitarerone and enzalutamide in asymp...
保存先:
| 出版年: | Eur J Hosp Pharm |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535378/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.202 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|